We are an iconic provider of hospital-based healthcare, striving to deliver an exceptional standard of care
We comprise several hospitals, health centres, a nationally accredited education provider and a world-class research institute
We are a nationally accredited, hospital-based Registered Training Organisation - the only one of its kind in Queensland
We are part of a collaborative research institute with The University of Queensland and founding partner of the Translational Research Institute
Health . Education . Research . Foundation
Newly appointed Acting Group Chief Executive Officer (CEO) at Mater Group, Professor John Prins, has shared his focus for his new role.
Taking over from Dr Shane Kelly, who commenced as CEO in 2015, Professor Prins said he is honoured to have been given the responsibility, following the enormous contribution made by Dr Shane Kelly.
“Dr Kelly established Mater Group as an integrated, singularly governed entity combining Mater Health, Mater Education, Mater Research and Mater Foundation. My focus is to build upon this foundation, with a strong emphasis on high quality performance, measured against international standards, across the Group,” said Professor Prins.
“We have a public and personal responsibility to ensure all patient care is of high standard and safe; that our education programs produce graduates in demand; that our research has broad clinical impact; and that our donors’ generosity is rewarded by efficient and purposeful use of funds.”
“We are immensely privileged to work ― and, for 700 of us, volunteer ― in an environment that is dedicated to improving the lives of others, and it’s important that we enjoy what we do!”
Prior to this role, Professor Prins was Chief Executive Officer of Mater Research and Director of MRI-UQ, and Professor of Endocrinology at the University of Queensland. He is actively involved in undergraduate and post-graduate teaching and training.
Professor Prins undertook his clinical training in endocrinology in Brisbane and completed a PhD in adipose tissue biology at The University of Queensland (UQ). His first postdoctoral research appointment was at the University of Cambridge, UK, based at Addenbrooke’s Hospital.
In 2004, Professor Prins founded the UQ Centre for Diabetes and Endocrine Research, which merged with the UQ Centre for Immunology and Cancer Research (CICR) in January 2007 to form the UQ Diamantina Institute. Professor Prins has continued parallel clinical, research and administrative activities.
Chair of the Mater Board, Brian Flannery, said Professor Prins is a well-known and valuable member of the Mater and Research communities.
“Professor John Prins is a clinician-scientist, a key opinion leader in diabetes and endocrinology in Australia and sits on numerous national and international scientific, clinical and educational committees and boards. He is an accomplished leader and we are delighted he has agreed to take this role.”
07 3163 1524
07 3163 6142
Mater Education’s first Virtual Open Day was a huge success, receiving a record number of registrations.
During National Myeloma Month, Richard agreed to share his story to help raise awareness of the disease.
COVID-19 isolation has proven no barrier for one Brisbane daughter who is on a mission to raise money for breast cancer in support of her recently-diagnosed mum ...
Mater continues to work as part of the broader health network in support of Public Health efforts to contain, treat and manage COVID-19.